Works matching IS 0278-0232 AND VI 39 AND IP 1 AND DT 2021
Results: 20
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 60, doi. 10.1002/hon.2822
- By:
- Publication type:
- Article
The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 3, doi. 10.1002/hon.2821
- By:
- Publication type:
- Article
A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 41, doi. 10.1002/hon.2820
- By:
- Publication type:
- Article
Diagnostic strategy for trigger identification in severe reactive hemophagocytic lymphohistiocytosis: A diagnostic accuracy study.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 114, doi. 10.1002/hon.2819
- By:
- Publication type:
- Article
Clinical trial risk in leukemia: Biomarkers and trial design.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 105, doi. 10.1002/hon.2818
- By:
- Publication type:
- Article
B cell receptor signaling related to resistance to Helicobacter pylori eradication therapy in gastric diffuse large B cell lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 145, doi. 10.1002/hon.2816
- By:
- Publication type:
- Article
Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 129, doi. 10.1002/hon.2815
- By:
- Publication type:
- Article
Increase of immunoglobulin A during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 141, doi. 10.1002/hon.2814
- By:
- Publication type:
- Article
Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 97, doi. 10.1002/hon.2813
- By:
- Publication type:
- Article
Outcomes of second hematopoietic stem cell transplantation using reduced‐intensity conditioning in an outpatient setting.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 87, doi. 10.1002/hon.2812
- By:
- Publication type:
- Article
Extended follow‐up of CD4<sup>+</sup> T cell recovery kinetics in a large cohort of patients with B‐cell lymphoproliferative disease treated with rituximab‐bendamustine.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 137, doi. 10.1002/hon.2797
- By:
- Publication type:
- Article
Hematopoietic stem cell transplantation for diffuse large B‐cell lymphoma having 8q24/MYC rearrangement in Japan.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 66, doi. 10.1002/hon.2811
- By:
- Publication type:
- Article
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 123, doi. 10.1002/hon.2808
- By:
- Publication type:
- Article
Humanized anti‐CD19 chimeric antigen receptor‐T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 75, doi. 10.1002/hon.2807
- By:
- Publication type:
- Article
Recent advances in chimeric antigen receptor natural killer cell therapy for overcoming intractable hematological malignancies.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 11, doi. 10.1002/hon.2802
- By:
- Publication type:
- Article
Consolidation with <sup>90</sup>Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 51, doi. 10.1002/hon.2809
- By:
- Publication type:
- Article
Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem‐cell transplantation: Real‐life experience.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 134, doi. 10.1002/hon.2796
- By:
- Publication type:
- Article
The role of long non‐coding RNAs and downstream signaling pathways in leukemia progression.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 27, doi. 10.1002/hon.2776
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 1, doi. 10.1002/hon.2745
- Publication type:
- Article
Management of patients with acute myeloid leukemia undergoing therapy with midostaurin: a focus on antifungal prophylaxis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 20, doi. 10.1002/hon.2788
- By:
- Publication type:
- Article